FDA Investigator Robert L Stevenson

Robert L Stevenson has conducted inspections on 5 sites in 3 countries as of 13 Jun 2007. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

13 Jun 2007

Investigator Role:

FDA Investigator

Redica ID:

100009182

Countries of Inspections:

Ireland, France, United States of America

FDA Investigators that have inspected at least one site in common with Robert L Stevenson:

Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ann Marie Montemurro, Anna Flynn, Brian D Nicholson, Bruce H Mccullough, Carla A Norris, Carrie Ann Plucinski, Chad E Schmear, Chiang Syin, PhD, Creighton T Tuzon, Cynthia Jim, CSO, Daniel C Kearns, Daniel Kearns, Debra I Love, Debra Lboyd Seale, Dolores Harper, Dr. Guang Gao, PhD, Elias N Paz Alonzo, Elliot P Cowam, PhD, Eric M Mueller, PharmD, Gene D Arcy, Gwyn G Dickinson, Helen B Ricalde, Humera T Khan, Jacqueline Mdiaz Albertini, James W Plucinski, Jan B Welch, Jason F Chancey, Jeanne M Morris, Jesse A Vazquez, Joan A Loreng, Joseph A Morkunas, Julie D Bringger, Karen Emasley Joseph, Kathleen B Swat, Kimberly L Anderson, Kimberly Lewandowski Walker, Kujtim Sadiku, Lakisha M Williams, Laurie A Haxel, LCDR Debra Emerson, Lequita M Mayhew, Lisa Hornback, Lixia Cai, Lorelei S Jarrell, Marcus F Yambot, Margaret M Annes, Margaret Torres Vazquez, Marie F Morin, Mark R Mcclain, Martha T Olone, Maureen C Melvin, Michael D Robinson, Michelle L Tripp, Mra Mcculloughj, Nicholas F Lyons, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman Wong, Omotunde O Osunsanmi, Paula A Trost, Philip F Istafanos, DMV, MS, Prabhu P Raju, Priscilla M Pastrana, Rafael Padilla, Rebecca Rodriguez, Reginald D Neal, Richard T Riggie, Roberta W Cunningham, Rose Ashley, Rumany C Penn, PharmD, Russell K Riley, Sarah B Tanksley, Seema S Singh, Sharmila Shrestha, Sidney B Priesmeyer, Stephen D Eich, Susan A Zullo, PhD, Susan F Laska, MS, Susan M Jackson, Tamara Brey, Temar Q Williams, Todd M Stankewicz, Wayne E Seifert

Robert L Stevenson's Documents

Publish Date	Document Type	Title
February, 2002	FDA 483 Response	Allergan Pharmaceuticals Ireland - Form 483R, 2002-02-27
May, 2007	EIR	Abbott Laboratories - EIR, 2007-05-02
February, 2002	FDA 483	Allergan Pharmaceuticals (Ireland) Ltd. - Form 483, 2002-02-21
February, 2002	EIR	Allergan Pharmaceuticals Ireland - EIR, 2006-05-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more